Boditech Med Inc. (206640.KQ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	174.7B	162.0B	138.2B	134.2B	118.1B
Cost of Revenue	72.1B	66.0B	56.4B	53.7B	50.7B
Gross Profit	102.6B	96.0B	81.8B	80.5B	67.4B
Operating Expenses
R&D Expense	21.0B	18.6B	16.0B	13.4B	14.7B
SG&A Expense	22.2B	20.2B	14.2B	33.6B	27.0B
General & Admin Expense	6.6B	5.9B	4.7B	4.1B	4.1B
Selling & Marketing Expense	15.6B	14.4B	9.5B	9.5B	6.8B
Other Expenses	35.6B	28.2B	25.5B	25.4B	2.4B
Total Operating Expenses	73.9B	67.0B	55.6B	47.1B	44.1B
Cost and Expenses	148.0B	133.1B	112.0B	100.8B	94.8B
Operating Income (EBIT)	26.7B	28.9B	26.2B	33.4B	23.3B
Non-Operating
Interest Income	4.2B	4.3B	1.0B	663.8M	332.2M
Interest Expense	4.5B	4.3B	352.5M	350.4M	203.9M
Net Interest Income	(267.1M)	(62.6M)	678.0M	313.4M	128.3M
Other Non-Op Income/Expense	5.3B	(1.1B)	6.3B	(1.9B)	3.6B
Non-Operating Income (excl Interest)	(5.8B)	748.3M	(6.6B)	5.2B	4.3B
EBT (Pre-Tax Income)	32.0B	27.8B	32.4B	31.6B	27.0B
Income Tax Expense	5.7B	3.9B	5.2B	4.9B	1.7B
Bottom Line
Net Income	26.0B	23.7B	27.3B	25.9B	24.2B
Earnings from Cont. Ops	26.3B	23.9B	27.2B	26.7B	25.3B
Earnings from Discont. Ops	—	—	—	—	(1.9K)
Bottom Line Net Income	26.0B	23.7B	27.3B	25.9B	24.2B
Per Share
Basic EPS	₩1,224	₩1,092	₩1,242	₩1,181	₩1,080
Diluted EPS	₩1,224	₩1,092	₩1,242	₩1,181	₩1,080
Revenue Per Share	₩8,038	₩7,473	₩6,297	₩6,110	₩5,280
Shares
Basic Shares Outstanding	21.7M	21.7M	21.9M	22.0M	22.4M
Diluted Shares Outstanding	21.7M	21.7M	21.9M	22.0M	22.4M
Profitability Metrics
EBITDA	28.1B	38.3B	41.2B	40.2B	35.0B
D&A	10.0B	10.1B	8.4B	8.2B	7.5B
EBIT	18.0B	28.2B	32.8B	31.9B	24.7B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026